Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報

【英語タイトル】Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(DATA904C4460)・商品コード:DATA904C4460
・発行会社(調査会社):MarketLine
・発行日:2018年8月
・ページ数:54
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,725見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,450見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,175見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report
Summary

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vertex Pharmaceuticals Incorporated (Vertex or ‘the company’) is a biotechnology company engaged in the discovery, development and commercialization of new medicines. Vertex operates R&D facilities in California, Washington D.C., Iowa, Canada, Switzerland, the UK, France, Germany, Australia, Ireland, Spain, Italy and the Netherlands. The company primarily operates in the US, Canada and Europe. It is headquartered in Boston, Massachusetts.

Scope

- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vertex Pharmaceuticals Incorporated: Company Overview 9
Vertex Pharmaceuticals Incorporated: Overview and Key Facts 9
Vertex Pharmaceuticals Incorporated: Overview 9
Vertex Pharmaceuticals Incorporated: Key Facts 9
Vertex Pharmaceuticals Incorporated: Key Employees 10
Vertex Pharmaceuticals Incorporated: Key Employee Biographies 12
Vertex Pharmaceuticals Incorporated: Major Products and Services 20
Vertex Pharmaceuticals Incorporated: Company History 21
Vertex Pharmaceuticals Incorporated: Management Statement 27
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries 29
Vertex Pharmaceuticals Incorporated: Key Competitors 30
Vertex Pharmaceuticals Incorporated: Company Analysis 31
Vertex Pharmaceuticals Incorporated: Business Description 31
Vertex Pharmaceuticals Incorporated: SWOT Analysis 33
Vertex Pharmaceuticals Incorporated: SWOT Overview 33
Vertex Pharmaceuticals Incorporated: Strengths 33
Vertex Pharmaceuticals Incorporated: Weaknesses 34
Vertex Pharmaceuticals Incorporated: Opportunities 34
Vertex Pharmaceuticals Incorporated: Threats 34
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity 36
Vertex Pharmaceuticals Incorporated: Financial Deals Overview 36
Vertex Pharmaceuticals Incorporated: Targets and Partners 38
Vertex Pharmaceuticals Incorporated: Top Deals 2014 – 2018YTD* 39
Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions 40
Vertex Pharmaceuticals Incorporated: Corporate Venturing 41
Vertex Pharmaceuticals Incorporated: Partnership 42
Vertex Pharmaceuticals Incorporated: Recent Developments 43
Vertex Pharmaceuticals Incorporated: News and Events Summary 43
Vertex Pharmaceuticals Incorporated: Business Expansion 46
Vertex Pharmaceuticals Incorporated: Corporate Governance 47
Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility 47
Vertex Pharmaceuticals Incorporated: Financial Performance 49
Vertex Pharmaceuticals Incorporated: Grants 50
Vertex Pharmaceuticals Incorporated: Strategy and Operations 51
Appendix 52
Contact Us 52
Methodology 52
About MarketLine 53

List of Tables
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 9: Vertex Pharmaceuticals Incorporated: Top Deals 2014 - 2018YTD*
Table 10: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 16: Vertex Pharmaceuticals Incorporated: Business Expansion
Table 17: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 18: Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Table 19: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 20: Vertex Pharmaceuticals Incorporated: Grants
Table 21: Vertex Pharmaceuticals Incorporated: Strategy and Operations

List of Figures
Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2014 - YTD*2018)

★調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報] (コード:DATA904C4460)販売に関する免責事項を必ずご確認ください。
★調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆